Frontiers in Clinical Drug Research Anti-Cancer Agents/ Atta-ur-Rahman, FRS
Material type:
TextSeries: ; Vol. 5Publication details: UAE:; Bentham Science Publisher,; 2019.Description: 187 pagesISBN: - 978-981-14-0514-3
- 981140514X
| Item type | Current library | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
Book
|
Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | RM301.27.F76_2019 (Browse shelf(Opens below)) | Available | P 2981 |
Browsing Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library shelves Close shelf browser (Hides shelf browser)
| No cover image available | No cover image available |
|
No cover image available | No cover image available |
|
|
||
| RM301.27.A88_2020 Frontiers in Clinical Drug Research CNS and Neurological Disorders | RM301.27.A88_2020 Frontiers in Clinical Drug Research CNS and Neurological Disorders/ | RM301.27.F76_2015 Frontiers in Clinical Drug Research Anti-Cancer Agents/ | RM301.27.F76_2019 Frontiers in Clinical Drug Research Anti-Cancer Agents/ | RM301.27.F76_2021 Frontiers in Clinical Drug Research Anti-Cancer Agents/ | RM301.27.F76_2021 Frontiers in Clinical Drug Research Anti-Cancer Agents/ | RM267.F76_2021 Frontiers in Anti-infective drug discovery/ |
Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.
The fifth volume of the book features reviews on biochemical inhibitors (second-generation protein kinase Inhibitors, histone deacetylase inhibitors, immune checkpoint inhibitors, EGFR Tyrosine Kinase inhibitors, non-coding RNAs), apoptosis, and physical exercise therapy for cancer patients undergoing chemotherapy. The treatment strategies in this volume cover cancers such as acute myeloid leukemia, gastrointestinal cancer, breast cancer and lung cancer.